These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20685405)

  • 21. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo.
    Cardillo C; Kilcoyne CM; Cannon RO; Panza JA
    Hypertension; 2000 Jun; 35(6):1237-41. PubMed ID: 10856270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise.
    Van Guilder GP; Westby CM; Greiner JJ; Stauffer BL; DeSouza CA
    Hypertension; 2007 Aug; 50(2):403-9. PubMed ID: 17576858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex-specific effects of cardiovascular risk factors on endothelium-dependent dilation and endothelin activity in middle-aged women and men.
    Brar V; Gill S; Cardillo C; Tesauro M; Panza JA; Campia U
    PLoS One; 2015; 10(3):e0121810. PubMed ID: 25807234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasoconstrictor effect of endothelin-1 in human skin: role of ETA and ETB receptors.
    Lipa JE; Neligan PC; Perreault TM; Baribeau J; Levine RH; Knowlton RJ; Pang CY
    Am J Physiol; 1999 Feb; 276(2):H359-67. PubMed ID: 9950834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Favorable Vascular Actions of Angiotensin-(1-7) in Human Obesity.
    Schinzari F; Tesauro M; Veneziani A; Mores N; Di Daniele N; Cardillo C
    Hypertension; 2018 Jan; 71(1):185-191. PubMed ID: 29203627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis.
    Helmy A; Jalan R; Newby DE; Johnston NR; Hayes PC; Webb DJ
    Hepatology; 2001 Apr; 33(4):826-31. PubMed ID: 11283846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats.
    Gardiner SM; Kemp PA; March JE; Bennett T; Davenport AP; Edvinsson L
    Br J Pharmacol; 1994 Jun; 112(2):477-86. PubMed ID: 8075866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary vasodilation and improvement in endothelial dysfunction with endothelin ET(A) receptor blockade.
    Halcox JP; Nour KR; Zalos G; Quyyumi AA
    Circ Res; 2001 Nov; 89(11):969-76. PubMed ID: 11717152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelin-1 and vascular tone in subjects with atherogenic risk factors.
    Nohria A; Garrett L; Johnson W; Kinlay S; Ganz P; Creager MA
    Hypertension; 2003 Jul; 42(1):43-8. PubMed ID: 12756218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The vascular endothelin system is not overactive in normotensive hemodialysis patients.
    Büssemaker E; Passauer J; Reimann D; Schulze B; Reichel W; Gross P
    Kidney Int; 2002 Sep; 62(3):940-8. PubMed ID: 12164876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased activity of endogenous endothelin in patients with type II diabetes mellitus.
    Cardillo C; Campia U; Bryant MB; Panza JA
    Circulation; 2002 Oct; 106(14):1783-7. PubMed ID: 12356630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired modulation of postjunctional α
    Kruse NT; Hughes WE; Ueda K; Hanada S; Feider AJ; Iwamoto E; Bock JM; Casey DP
    J Physiol; 2018 Jul; 596(13):2507-2519. PubMed ID: 29708589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Sudano I; Notari M; Salvetti A
    Circulation; 1999 Oct; 100(16):1680-3. PubMed ID: 10525485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose- and time-dependency of the dilator effects of the endothelin antagonist, BQ-123, in the human forearm.
    Berrazueta JR; Bhagat K; Vallance P; MacAllister RJ
    Br J Clin Pharmacol; 1997 Dec; 44(6):569-71. PubMed ID: 9431833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists.
    Allcock GH; Warner TD; Vane JR
    Br J Pharmacol; 1995 Nov; 116(5):2482-6. PubMed ID: 8581288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Forearm endothelial function and bone mineral loss in postmenopausal women.
    Sanada M; Taguchi A; Higashi Y; Tsuda M; Kodama I; Yoshizumi M; Ohama K
    Atherosclerosis; 2004 Oct; 176(2):387-92. PubMed ID: 15380463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
    Warner TD; Allcock GH; Vane JR
    Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role and mechanism of endothelin-B receptors in mediating ET-1-induced vasoconstriction in pig skin.
    Pang CY; Zhang J; Xu H; Lipa JE; Forrest CR; Neligan PC
    Am J Physiol; 1998 Oct; 275(4):R1066-74. PubMed ID: 9756535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous endothelin generation maintains vascular tone in humans.
    Webb DJ
    J Hum Hypertens; 1995 Jun; 9(6):459-63. PubMed ID: 7473528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selected contribution: Gender differences in the endothelin-B receptor contribution to basal cutaneous vascular tone in humans.
    Kellogg DL; Liu Y; Pérgola PE
    J Appl Physiol (1985); 2001 Nov; 91(5):2407-11; discussion 2389-90. PubMed ID: 11641388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.